More News
16 December 2021
Chugai In-Licenses Gene Therapy Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy14 December 2021
Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics’ TCR Bispecific Program IMA40114 December 2021
Biogen and TheraPanacea Announce New Collaboration with the Potential to Advance Digital Health for Personalized Medicine in Neuroscience14 December 2021
CSL Limited Announces Tender Offer To Acquire Vifor Pharma Ltd14 December 2021
Molecular Partners Announces Collaboration with Novartis to Develop DARPin-Conjugated Radioligand Therapeutic Candidates for Oncology13 December 2021
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn’s Proprietary Gene Traffic Control® Platform13 December 2021
Pfizer to Acquire Arena Pharmaceuticals10 December 2021
Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders7 December 2021
Recordati to acquire EUSA Pharma (UK) Ltd, a global specialty pharmaceutical company focused on rare and niche oncology diseases2 December 2021
ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors2 December 2021
UCB Announces Global Partnership To Bring Disease-Modifying Therapies To People Living With Parkinson’s Disease2 December 2021
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy2 December 2021
Curie Therapeutics Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals30 November 2021
Confo Therapeutics Enters Collaborative Agreement with Regeneron24 November 2021
Philogen announces new collaboration with Janssen to discover small molecule therapeutics22 November 2021
Baidu Enters Into License Agreement With Sanofi to Enable Next-Generation mRNA Therapeutics and Vaccines22 November 2021
Vifor Pharma to spearhead development of vascular calcification field, through acquisition of Sanifit Therapeutics and Inositec AG19 November 2021
Gilead Exercises Options to Three Arcus Biosciences Clinical-Stage Programs and Adds Research CollaborationNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports